HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS
Provided herein are Heteroaryl Compounds having the following structure: wherein R1, R3, R4, L, X, Y, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions,...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | ALBERS, RONALD J PARNES, JASON SIMON HEDGE, SAYEE, G RIGGS, JENNIFER R MCKENNA, JEFFREY, M SAPIENZA, JOHN JOSEPH SCHWARZ, KIMBERLY LYN PAPA, PATRICK WILLIAM CLAREEN, STEVEN, S MORTENSEN, DEBORAH SUE MEDEROS, MARIA MERCEDES DELGADO |
description | Provided herein are Heteroaryl Compounds having the following structure: wherein R1, R3, R4, L, X, Y, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2078018B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2078018B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2078018B13</originalsourceid><addsrcrecordid>eNrjZIjwcA1xDfJ3DIr0UXD29w3wD_VzCdaBMIM9Qzz9_YIVQjxcg1z93XQUHP1cFEKDXWECCo7BCgFB_iGunn4K3p5-jkAZTz8PTyfPEP-gYB4G1rTEnOJUXijNzaDg5hri7KGbWpAfn1pckJicmpdaEu8aYGRgbmFgaOFkaEyEEgC6JTEY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS</title><source>esp@cenet</source><creator>ALBERS, RONALD J ; PARNES, JASON SIMON ; HEDGE, SAYEE, G ; RIGGS, JENNIFER R ; MCKENNA, JEFFREY, M ; SAPIENZA, JOHN JOSEPH ; SCHWARZ, KIMBERLY LYN ; PAPA, PATRICK WILLIAM ; CLAREEN, STEVEN, S ; MORTENSEN, DEBORAH SUE ; MEDEROS, MARIA MERCEDES DELGADO</creator><creatorcontrib>ALBERS, RONALD J ; PARNES, JASON SIMON ; HEDGE, SAYEE, G ; RIGGS, JENNIFER R ; MCKENNA, JEFFREY, M ; SAPIENZA, JOHN JOSEPH ; SCHWARZ, KIMBERLY LYN ; PAPA, PATRICK WILLIAM ; CLAREEN, STEVEN, S ; MORTENSEN, DEBORAH SUE ; MEDEROS, MARIA MERCEDES DELGADO</creatorcontrib><description>Provided herein are Heteroaryl Compounds having the following structure: wherein R1, R3, R4, L, X, Y, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120314&DB=EPODOC&CC=EP&NR=2078018B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120314&DB=EPODOC&CC=EP&NR=2078018B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ALBERS, RONALD J</creatorcontrib><creatorcontrib>PARNES, JASON SIMON</creatorcontrib><creatorcontrib>HEDGE, SAYEE, G</creatorcontrib><creatorcontrib>RIGGS, JENNIFER R</creatorcontrib><creatorcontrib>MCKENNA, JEFFREY, M</creatorcontrib><creatorcontrib>SAPIENZA, JOHN JOSEPH</creatorcontrib><creatorcontrib>SCHWARZ, KIMBERLY LYN</creatorcontrib><creatorcontrib>PAPA, PATRICK WILLIAM</creatorcontrib><creatorcontrib>CLAREEN, STEVEN, S</creatorcontrib><creatorcontrib>MORTENSEN, DEBORAH SUE</creatorcontrib><creatorcontrib>MEDEROS, MARIA MERCEDES DELGADO</creatorcontrib><title>HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS</title><description>Provided herein are Heteroaryl Compounds having the following structure: wherein R1, R3, R4, L, X, Y, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIjwcA1xDfJ3DIr0UXD29w3wD_VzCdaBMIM9Qzz9_YIVQjxcg1z93XQUHP1cFEKDXWECCo7BCgFB_iGunn4K3p5-jkAZTz8PTyfPEP-gYB4G1rTEnOJUXijNzaDg5hri7KGbWpAfn1pckJicmpdaEu8aYGRgbmFgaOFkaEyEEgC6JTEY</recordid><startdate>20120314</startdate><enddate>20120314</enddate><creator>ALBERS, RONALD J</creator><creator>PARNES, JASON SIMON</creator><creator>HEDGE, SAYEE, G</creator><creator>RIGGS, JENNIFER R</creator><creator>MCKENNA, JEFFREY, M</creator><creator>SAPIENZA, JOHN JOSEPH</creator><creator>SCHWARZ, KIMBERLY LYN</creator><creator>PAPA, PATRICK WILLIAM</creator><creator>CLAREEN, STEVEN, S</creator><creator>MORTENSEN, DEBORAH SUE</creator><creator>MEDEROS, MARIA MERCEDES DELGADO</creator><scope>EVB</scope></search><sort><creationdate>20120314</creationdate><title>HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS</title><author>ALBERS, RONALD J ; PARNES, JASON SIMON ; HEDGE, SAYEE, G ; RIGGS, JENNIFER R ; MCKENNA, JEFFREY, M ; SAPIENZA, JOHN JOSEPH ; SCHWARZ, KIMBERLY LYN ; PAPA, PATRICK WILLIAM ; CLAREEN, STEVEN, S ; MORTENSEN, DEBORAH SUE ; MEDEROS, MARIA MERCEDES DELGADO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2078018B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ALBERS, RONALD J</creatorcontrib><creatorcontrib>PARNES, JASON SIMON</creatorcontrib><creatorcontrib>HEDGE, SAYEE, G</creatorcontrib><creatorcontrib>RIGGS, JENNIFER R</creatorcontrib><creatorcontrib>MCKENNA, JEFFREY, M</creatorcontrib><creatorcontrib>SAPIENZA, JOHN JOSEPH</creatorcontrib><creatorcontrib>SCHWARZ, KIMBERLY LYN</creatorcontrib><creatorcontrib>PAPA, PATRICK WILLIAM</creatorcontrib><creatorcontrib>CLAREEN, STEVEN, S</creatorcontrib><creatorcontrib>MORTENSEN, DEBORAH SUE</creatorcontrib><creatorcontrib>MEDEROS, MARIA MERCEDES DELGADO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ALBERS, RONALD J</au><au>PARNES, JASON SIMON</au><au>HEDGE, SAYEE, G</au><au>RIGGS, JENNIFER R</au><au>MCKENNA, JEFFREY, M</au><au>SAPIENZA, JOHN JOSEPH</au><au>SCHWARZ, KIMBERLY LYN</au><au>PAPA, PATRICK WILLIAM</au><au>CLAREEN, STEVEN, S</au><au>MORTENSEN, DEBORAH SUE</au><au>MEDEROS, MARIA MERCEDES DELGADO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS</title><date>2012-03-14</date><risdate>2012</risdate><abstract>Provided herein are Heteroaryl Compounds having the following structure: wherein R1, R3, R4, L, X, Y, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP2078018B1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T04%3A36%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ALBERS,%20RONALD%20J&rft.date=2012-03-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2078018B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |